Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Koehler

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Minerva Urology and Nephrology|December 21, 2023
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancerFrancesca Ambrosini, Fabian Falkenbach, Lars Budaeus, et al.
Cancers|October 28, 2023
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate CancerFabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt, et al.
World Journal of Urology|July 29, 2023
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS supportFabian Falkenbach, Sophie Knipper, Daniel Koehler, et al.
European Journal of Human Genetics : EJHG|January 15, 2009
Linkage analysis of left ventricular outflow tract malformations (aortic valve stenosis, coarctation of the aorta, and hypoplastic left heart syndrome)Kim L McBride, Gloria A Zender, Sara M Fitzgerald-Butt, et al.
European Urology Open Science|January 17, 2025
Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen-targeted Radioguided Surgery for Oligorecurrent Prostate CancerFabian Falkenbach, Giovanni Mazzucato, Zhe Tian, et al.
Frontiers in Pharmacology|April 26, 2018
Differential Toxicity of mDia Formin-Directed Functional Agonists and Antagonists in Developing ZebrafishHunter LeCorgne, Andrew M Tudosie, Kari Lavik, et al.
Cancers|January 11, 2025
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI<sup>®</sup> Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final HistologyGiovanni Mazzucato, Fabian Falkenbach, Marie-Lena Schmalhofer, et al.
European Urology Focus|January 22, 2025
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic TreatmentFabian Falkenbach, Flemming Lischewski, Sophie Knipper, et al.
BJU International|May 19, 2025
Robot-assisted PSMA-radioguided surgery for local recurrence in the prostatic bedFabian Falkenbach, Giovanni Mazzucato, Marie-Lena Schmalhofer, et al.
European Urology|June 19, 2022
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Minerva Urology and Nephrology|December 21, 2023
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancerFrancesca Ambrosini, Fabian Falkenbach, Lars Budaeus, et al.
Cancers|October 28, 2023
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate CancerFabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt, et al.
World Journal of Urology|July 29, 2023
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS supportFabian Falkenbach, Sophie Knipper, Daniel Koehler, et al.
European Journal of Human Genetics : EJHG|January 15, 2009
Linkage analysis of left ventricular outflow tract malformations (aortic valve stenosis, coarctation of the aorta, and hypoplastic left heart syndrome)Kim L McBride, Gloria A Zender, Sara M Fitzgerald-Butt, et al.
European Urology Open Science|January 17, 2025
Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen-targeted Radioguided Surgery for Oligorecurrent Prostate CancerFabian Falkenbach, Giovanni Mazzucato, Zhe Tian, et al.
Frontiers in Pharmacology|April 26, 2018
Differential Toxicity of mDia Formin-Directed Functional Agonists and Antagonists in Developing ZebrafishHunter LeCorgne, Andrew M Tudosie, Kari Lavik, et al.
Cancers|January 11, 2025
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI<sup>®</sup> Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final HistologyGiovanni Mazzucato, Fabian Falkenbach, Marie-Lena Schmalhofer, et al.
European Urology Focus|January 22, 2025
Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic TreatmentFabian Falkenbach, Flemming Lischewski, Sophie Knipper, et al.
BJU International|May 19, 2025
Robot-assisted PSMA-radioguided surgery for local recurrence in the prostatic bedFabian Falkenbach, Giovanni Mazzucato, Marie-Lena Schmalhofer, et al.
European Urology|June 19, 2022
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al.
Pageof 6